Mettler-Toledo International (NYSE:MTD) Given New $1,580.00 Price Target at Jefferies Financial Group

Mettler-Toledo International (NYSE:MTD) had its target price hoisted by Jefferies Financial Group from $1,400.00 to $1,580.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Jefferies Financial Group’s price target would suggest a potential upside of 11.64% from the company’s current price.

A number of other brokerages also recently weighed in on MTD. Wolfe Research initiated coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. JPMorgan Chase & Co. lowered their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Citigroup reduced their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Weiss Ratings lowered Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 21st. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,420.36.

Mettler-Toledo International Price Performance

Shares of MTD traded up $34.63 during trading hours on Friday, hitting $1,415.24. 154,644 shares of the company were exchanged, compared to its average volume of 177,613. The company has a market capitalization of $28.60 billion, a PE ratio of 33.22, a PEG ratio of 2.90 and a beta of 1.24. The firm has a fifty day simple moving average of $1,231.02 and a 200-day simple moving average of $1,275.04. Mettler-Toledo International has a one year low of $1,023.05 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.80 by $0.66. The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $10.09 EPS. Sell-side analysts expect that Mettler-Toledo International will post 46.63 EPS for the current year.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently bought and sold shares of the business. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after buying an additional 109,508 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Mettler-Toledo International by 0.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after acquiring an additional 3,157 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Mettler-Toledo International by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after purchasing an additional 14,106 shares during the last quarter. Norges Bank acquired a new position in Mettler-Toledo International during the fourth quarter valued at approximately $520,989,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Mettler-Toledo International by 0.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 272,829 shares of the medical instruments supplier’s stock valued at $380,375,000 after purchasing an additional 1,052 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.